China SXT Pharmaceuticals, Inc. (SXTC): Shareholders' Equity
$29.71M
As of 2026-03-31
+26.5%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $29.71M | +92.4% | 2026-07-01, Balance as of period end |
| 2025-03-31 | $15.44M | +10.8% | 2026-07-01, Balance as of period end |
| 2024-03-31 | $13.93M | -5.2% | 2026-07-01, Balance as of period end |
| 2023-03-31 | $14.69M | n/c | 2025-07-31, Balance as of period end |
| 2022-03-31 | $16.42M | +2.9% | 2024-08-13, Balance as of period end |
| 2021-03-31 | $15.96M | +69.8% | 2023-07-31, Balance as of period end |
| 2020-03-31 | $9.40M | -15.4% | 2023-05-19, Balance as of period end |
| 2019-03-31 | $11.11M | +238.1% | 2021-08-13, Balance as of period end |
| 2018-03-31 | $3.29M | +77.4% | 2020-07-31, Balance as of period end |
| 2017-03-31 | $1.85M | n/a | 2019-08-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $29.71M | +92.4% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | -$2.09M | n/m |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $24.60M | +29.5% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $5.67M | -74.1% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $2.84M | n/m |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $35.52M | -49.5% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $6.33M | -13.5% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $3.46M | -14.2% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $82.39M | +3.5% |
Compare SXTC, BSPK, NEUP, LGVN side by side · Screen every company in Pharmaceutical Preparations ↗